Skip to main content
SpringerLink
Log in

Ovar

  • Chapter
  • First Online:
Pathologie

Part of the book series: Pathologie ((PATHOL))

  • 6389 Accesses

Zusammenfassung

Nach einer Rekapitulation der Embryologie, Anatomie und Physiologie des Ovars werden Fehlentwicklungen unter Einschluss von Intersexsyndromen dargestellt. Auf die Morphologie von funktionellen Störungen wird ausführlich eingegangen. Schwerpunkt des Kapitels sind die Tumoren des Ovars, die entsprechend der gültigen WHO-Klassifikation beschrieben werden. Dabei werden auch aktuelle Konzepte zur Histogenese des Ovarialkarzinoms umrissen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Notes

  1. 1.

    Cave: Dies sind alles Begriffe, die nicht mehr verwendet werden sollten!

Literatur

  1. Ahmed AA, Etemadmoghadam D, Temple J et al (2010) Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 221:49–56

    Article  PubMed  CAS  Google Scholar 

  2. Baker TG, Sum W (1976) Development of the ovary and oogenesis. Clin Obstet Gynecol 3:3–26

    CAS  Google Scholar 

  3. Bast Jr RC, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9:415–428

    Article  PubMed  CAS  Google Scholar 

  4. Beral V (1987) Epidemiology. In: Sharp F, Soutter WP (eds) Ovarian cancer – the way ahead. Royal College of Obstetricians and Gynaecologists, London, p 26

    Google Scholar 

  5. Bingham C, Roberts D, Hamilton TC (2001) The role of molecular biology in understanding ovarian cancer initiation and progression. Int J Gynecol Cancer 11(Suppl 1):7–11

    Article  PubMed  Google Scholar 

  6. Björkholm E, Silfverswärd C (1981) Prognostic factors in granulosa cell tumors. Gynec Oncol 11:261–275

    Article  Google Scholar 

  7. Bonome T, Lee JY, Park DC et al (2005) Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res 65:10602–10612

    Article  PubMed  CAS  Google Scholar 

  8. Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumors of the digestive system. IARC Press, Lyon

    Google Scholar 

  9. Bowtell DD (2010) The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 10:803–808

    Article  PubMed  CAS  Google Scholar 

  10. Bukovsky A, Caudle MR, Svetlikova M, Upadhyaya NB (2004) Origin of germ cells and formation of new primary follicles in adult human ovaries. Reprod Biol Endocrinol 2:20

    Article  PubMed  Google Scholar 

  11. Burks RT, Sherman ME, Kurman RJ (1996) Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 20:1319–1330

    Article  PubMed  CAS  Google Scholar 

  12. Catasús L, Bussaglia E, Rodrguez I, Gallardo A, Pons C, Irving JA, Prat J (2004) Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol 35:1360–1368

    Article  PubMed  Google Scholar 

  13. Cathro HP, Stoler MH (2005) The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol 36:195–201

    Article  PubMed  CAS  Google Scholar 

  14. Chikazawa K, Araki S, Tamada T (1986) Morphological and endocrinological studies on follicular development during the human menstrual cycle. J Clin Endocrinol Metab 62:305–313

    Article  PubMed  CAS  Google Scholar 

  15. Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717–721

    PubMed  CAS  Google Scholar 

  16. Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, Lee Y (2007) The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19:3–9

    Article  PubMed  Google Scholar 

  17. Dehari R, Kurman RJ, Logani S, Shih IM (2007) The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis. Am J Surg Pathol 31:1007–1012

    Article  PubMed  Google Scholar 

  18. Dietel M (1982) Facultative malignant ovarian tumors. In: Dallenbach-Hellweg G (ed) Ovarialtumoren. Springer, Berlin Heidelberg New York, pp 181–193

    Chapter  Google Scholar 

  19. Dietel M, Hauptmann S (2000) Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology. Virchows Arch 436:403–412

    Article  PubMed  CAS  Google Scholar 

  20. Engel E, Forbes AP (1965) Cytogenetic and clinical findings in 48 patients with congenitally defective or absent ovaries. Medicine (Baltimore) 44:135–164

    CAS  Google Scholar 

  21. Fathalla MF (1971) Incessant ovulation – a factor in ovarian neoplasia. Lancet 17:163

    Article  Google Scholar 

  22. Frumovitz M, Schmeler KM, Malpica A, Sood AK, Gershenson DM (2010) Unmasking the complexities of mucinous ovarian carcinoma. Gynecol Oncol 117:491–496

    Article  PubMed  Google Scholar 

  23. Gilks CB, Prat J (2009) Ovarian carcinoma pathology and genetics: recent advances. Hum Pathol 40:1213–1223

    Article  PubMed  CAS  Google Scholar 

  24. Giroud F, Haroske G, Reith A, Bocking A (1997) ESACP consensus report on diagnostic DNA image cytometry. Part II: Specific recommendations for quality assurance. European Society for Analytical Cellular Pathology. Anal Cell Pathol 17:201–208

    Google Scholar 

  25. Hamilton WJ, Mossman HW (1972) Hamilton, Boyd and Mossman's Human embryology, 4th edn. Heffer, Cambridge, p 406

    Google Scholar 

  26. Healy DL, Burger HG, Mamers P et al (1993) Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 329:1539–1542

    Article  PubMed  CAS  Google Scholar 

  27. Jensen RD, Norris HJ (1972) Epithelial tumors of the ovary. Occurence in children and adolescents less than 20 years of age. Arch Pathol 94:29–34

    PubMed  CAS  Google Scholar 

  28. Kaern J, Trope C, Kjorstad KE, Abeler V, Pettersen EO (1990) Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary. Gynecol Oncol 38:452–457

    Article  PubMed  CAS  Google Scholar 

  29. Karseladze AI (2001) On the site of origin of epithelial tumors of the ovary. Eur J Gynaecol Oncol 22:110–115

    PubMed  CAS  Google Scholar 

  30. Kim MS, Hur SY, Yoo NJ, Lee SH (2010) Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. J Pathol 221:147–152

    Article  PubMed  CAS  Google Scholar 

  31. Kindelberger DW, Lee Y, Miron A et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 31:161–169

    Article  PubMed  Google Scholar 

  32. King BF, Enders AC (1993) The human yolk sac and yolk sac tumors. Springer, Berlin Heidelberg New York

    Google Scholar 

  33. Köbel M, Kalloger SE, Boyd N et al (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5:e232

    Article  PubMed  Google Scholar 

  34. Köbel M, Kalloger SE, Carrick J et al (2009) A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. Am J Surg Pathol 33:14–21

    Article  PubMed  Google Scholar 

  35. Kuo KT, Mao TL, Jones S et al (2009) Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol 174:1597–1601

    Article  PubMed  CAS  Google Scholar 

  36. Kurman RJ, Shih IeM (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34:433–443

    Article  PubMed  Google Scholar 

  37. Kurman RJ, Goebelsmann U, Taylor CR, Bchir MD (1981) Localiziation of steroid hormones in functional ovarian tumors. In: DeLellis RA (ed) Diagnostic immunhistochemistry. Masson, Paris

    Google Scholar 

  38. Lauchlan SC (1968) Conceptual unity of the müllerian tumor group. Cancer 22:601–610

    Article  PubMed  CAS  Google Scholar 

  39. Lee KR, Russell P, Tavassoli FH et al (2003) Surface epithelial-stromal tumours. Classification of Tumours. Tumours of the Breast and Female Genital Organs. IARC Press, Lyon, pp 113–202

    Google Scholar 

  40. Leung PCK, Armstrong DT (1980) Interactions of steroids and gonadotropins in the control of steroidgenesis in the ovarian follicle. Annu Rev Physiol 42:71–82

    Article  PubMed  CAS  Google Scholar 

  41. Lin WL, Kuo WH, Chen FL et al (2011) Identification of the Coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer. Ann Surg Oncol 18:2388–2394

    Article  PubMed  Google Scholar 

  42. Linder D, McCaw BK, Hecht F (1975) Pathenogenic origin of benign ovarian teratoma. New Engl J Med 292:63–66

    Article  PubMed  CAS  Google Scholar 

  43. Logani S, Oliva E, Amin MB, Folpe AL, Cohen C, Young RH (2003) Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications. Am J Surg Pathol 27:1434–1441

    Article  PubMed  Google Scholar 

  44. Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR (2005) Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol 29:707–723

    Article  PubMed  Google Scholar 

  45. MacLachlan TK, Somasundaram K, Sgagias M, Shifman Y, Muschel RJ, Cowan KH, El-Deiry WS (2000) BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem 275:2777–2785

    Article  PubMed  CAS  Google Scholar 

  46. McAlpine JN, Wiegand KC, Vang R et al (2009) HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy. BMC Cancer 9:433

    Article  PubMed  Google Scholar 

  47. McCluggage WG (2008) My approach to and thoughts on the typing of ovarian carcinomas. J Clin Pathol 61:152–163

    Article  PubMed  CAS  Google Scholar 

  48. McCluggage WG (2010) The pathology of and controversial aspects of ovarian borderline tumours. Curr Opin Oncol 22:462–472

    Article  PubMed  Google Scholar 

  49. McCluggage WG, Wilkinson N (2005) Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 47:231–247

    Article  PubMed  CAS  Google Scholar 

  50. McCluggage WG, Young RH (2005) Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol 22:3–32

    Article  PubMed  Google Scholar 

  51. McCluggage WG, Young RH (2007) Ovarian sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid sertoli-leydig cell tumors. Am J Surg Pathol 31:592–597

    Article  PubMed  Google Scholar 

  52. McKenney JK, Balzer BL, Longacre TA (2006) Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am J Surg Pathol 30:1209–1221

    Article  PubMed  Google Scholar 

  53. Medeiros F, Muto MG, Lee Y et al (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30:230–236

    Article  PubMed  Google Scholar 

  54. Miles PA, Norris HJ (1972) Proliferative and malignant Brenner tumors of the ovary. Cancer 30:174–180

    Article  PubMed  CAS  Google Scholar 

  55. Nakayama K, Masuzawa H, Li SF, Yoshikawa F, Toki T, Nikaido T, Silverberg SG, Fujii S (1994) Immunohistochemical analysis of the peritoneum adjacent to endometriotic lesions using antibodies for Ber-EP4 antigen, estrogen receptors, and progesterone receptors: implication of peritoneal metaplasia in the pathogenesis of endometriosis. Int J Gynecol Pathol 13:348–358

    Article  PubMed  CAS  Google Scholar 

  56. Ness RB, Cottreau C (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:1459–1467

    Article  PubMed  CAS  Google Scholar 

  57. Nogales F, Talerman A, Kubik-Huch RA, Tavassoli FA, Devouassoux-Shisheboran M (2003) Germ cell tumors. In: Tavassoli FA, Devilee P (eds) WHO classification of tumours. Tumours of the breast and female genital organs. IARC Press, Lyon, pp 163–175

    Google Scholar 

  58. Norris HJ, Taylor HB (1968) Prognosis of granulosa-theca tumors of the ovary. Cancer 21:255–263

    Article  PubMed  CAS  Google Scholar 

  59. Norris HJ, Zirkin HJ, Benson WL (1976) Immature (malignant) teratoma of the ovary. A clinical and pathological study of 58 cases. Cancer 37:2359–2372

    Article  PubMed  CAS  Google Scholar 

  60. O'Connor DM, Norris HJ (1994) The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol 13:283–289

    Article  PubMed  Google Scholar 

  61. Obata K, Morland SJ, Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, Campbell IG (1998) Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 58:2095–2097

    PubMed  CAS  Google Scholar 

  62. Oliva E, Alvarez T, Young RH (2005) Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 29:143–156

    Article  PubMed  Google Scholar 

  63. Ordóñez NG (2000) Transitional cell carcinomas of the ovary and bladder are immunophenotypically different. Histopathology 36:433–438

    Article  PubMed  Google Scholar 

  64. Padberg BC, Arps H, Franke U et al (1992) DNA cytophotometry and prognosis in ovarian tumors of borderline malignancy. A clinicomorphologic study of 80 cases. Cancer 69:2510–2514

    Article  PubMed  CAS  Google Scholar 

  65. Palacios J, Gamallo C (1998) Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 58:1344–1347

    PubMed  CAS  Google Scholar 

  66. Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA (2001) Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol 80:176–180

    Article  PubMed  CAS  Google Scholar 

  67. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153–156

    Article  PubMed  CAS  Google Scholar 

  68. Piek JM, van Diest PJ, Zweemer RP et al (2001) Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195:451–456

    Article  PubMed  CAS  Google Scholar 

  69. Pinkerton JM, McKay DG, Adams EC, Hertig AT (1961) Development of the human ovary – a study using histochemical techniquies. Obstet Gynecol 18:152–181

    PubMed  CAS  Google Scholar 

  70. Prat J, De Nictolis M (2002) Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 26:1111–1128

    Article  PubMed  Google Scholar 

  71. Prayson RA, Hart WR, Petras RE (1994) Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 18:591–603

    PubMed  CAS  Google Scholar 

  72. Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694–706

    Article  PubMed  CAS  Google Scholar 

  73. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (1995) Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 19:1390–408

    Article  PubMed  CAS  Google Scholar 

  74. Ronnett BM, Kurman RJ, Shmookler BM, Sugarbaker PH, Young RH (1997) The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 21:1144–1155

    Article  PubMed  CAS  Google Scholar 

  75. Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ (1997) Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 16:1–9

    Article  PubMed  CAS  Google Scholar 

  76. Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, Young RH (2004) Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 35:949–960

    Article  PubMed  Google Scholar 

  77. Russell P, Bannatyne PM, Solomon HJ, Stoddard LD, Tattersall MHN (1985) Multifocal tumorigenesis in the upper femal genital tract - implications for staging and management. Intern J Gynec Pathol 4:192–210

    Article  CAS  Google Scholar 

  78. Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60:7052–7056

    PubMed  CAS  Google Scholar 

  79. Schmutzler R, Schlegelberger B, Meindl A, Gerber WD, Kiechle M (2003) Beratung, Genetische Testung und Prävention von Frauen mit einer familiären Belastung für das Mamma- und Ovarialkarzinom Interdisziplinäre Empfehlungen des Konsortiums „Familiärer Brust- und Eierstockkrebs” der Deutschen Krebshilfe. Zentralbl Gynakol 125:494

    Article  PubMed  CAS  Google Scholar 

  80. Schrader KA, Gorbatcheva B, Senz J et al (2009)  The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors. PLoS One 4:e7988

    Article  PubMed  Google Scholar 

  81. Scully RE (1953) Gonadoblastoma. A gonadal tumor related to dysgerminoma (seminoma) and capable of sex hormone production. Cancer 6:455–463

    Article  PubMed  CAS  Google Scholar 

  82. Scully RE (1970) Sex cord tumor with annular tubules. A distintive ovarian tumor of the Peutz-Jeghers Syndrome. Cancer 25:1107–1121

    Article  PubMed  CAS  Google Scholar 

  83. Scully RE, Robert HY, Clement PB (1998) Extragonadal teratomas. Atlas of Tumor Pathology, 3rd Series,Fasc. 23. Armed Forces Inst Pathol, Washington D.C.

    Google Scholar 

  84. Seidman JD, Kurman RJ (2000) Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 31:539–557

    Article  PubMed  CAS  Google Scholar 

  85. Seidman JD, Russell P, Kurman RJ (2002) Surface epithelial tumors of the ovary. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract, 5th edn. Springer, Berlin Heidelberg New York, pp 791–904

    Google Scholar 

  86. Serov SF, Scully RE (1996) Histological classification of ovarian tumors. In: Histological typing of ovarian tumors. International classification of tumors. World Health Organization, Geneva

    Google Scholar 

  87. Shah SP, Köbel M, Senz J et al (2009) Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360:2719–2729

    Article  PubMed  CAS  Google Scholar 

  88. Shih Ie-M, Kurman RJ (2005) Molecular pathogenesis of ovarian borderline tumors: New insights and old challenges. Clin Cancer Res 11:7273–7279

    Article  Google Scholar 

  89. Singer G, Kurman RJ, Chang HW, Cho SK, Shih IeM (2002) Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol 160:1223–1228

    Article  PubMed  CAS  Google Scholar 

  90. Suh-Burgmann E (2006) Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol 103:841–847

    Article  PubMed  Google Scholar 

  91. Talerman A (1984) Carcinoid of the ovary. J Cancer Res Clin Oncol 107:125–135

    Article  PubMed  CAS  Google Scholar 

  92. Talerman A (2001) Germ cell tumors of the ovary. In: Blaustein A (ed) Pathology of the femal genital tract. Springer, Berlin Heidelberg New York

    Google Scholar 

  93. Tavassoli FA, Devilee P (eds) (2003) World Health Organization classification of tumours. Pathology and genetics of tumors of the breast and female genital organs. IARC Press, Lyon

    Google Scholar 

  94. Taylor HB, Norris HJ (1967) Lipid cell tumors of the ovary. Cancer 20:1953–1962

    Article  PubMed  CAS  Google Scholar 

  95. Teilum G (1965) Classification of endodermal sinus tumour (mesoblastoma vitellinum) and so-called „embryonal carcinoma“ of the ovary. Acta Path Microbiol Scand 64:407–413

    PubMed  CAS  Google Scholar 

  96. Teilum G (1976) Special tumors of the ovary and testis. Munksgaard, Kopenhagen

    Google Scholar 

  97. Val P, Swain A (2005) Mechanisms of disease: normal and abnormal gonadal development and sex determination in mammals. Nat Clin Pract Urol 2:616–627

    Article  PubMed  Google Scholar 

  98. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM (2006) Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol 19:97–105

    Article  PubMed  CAS  Google Scholar 

  99. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM (2006) Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int J Gynecol Pathol 25:83–89

    Article  PubMed  Google Scholar 

  100. Yaziji HMD, Gown AMMD (2001) Immunohistochemical analysis of gynecologic tumors. Int J Gyn Path 20:64–78

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Manfred Dietel Prof. Dr. med. & Silvia Darb-Esfahani Dr. med.

    Present address: Direktor, Institut für Pathologie, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Charité-Platz 1, 10117, Berlin, Deutschland

  2. Carsten Denkert Prof. Dr. med.

    Present address: Institut für Pathologie, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Charité-Platz 1, 10117, Berlin, Deutschland

Authors and Affiliations

    Authors
    1. Manfred Dietel Prof. Dr. med.
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Carsten Denkert Prof. Dr. med.
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Silvia Darb-Esfahani Dr. med.
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Manfred Dietel Prof. Dr. med. , Carsten Denkert Prof. Dr. med. or Silvia Darb-Esfahani Dr. med. .

    Editor information

    Editors and Affiliations

    1. Institut für Pathologie, Konsultationszentrum für Pankreas- und, TU München, Ismaninger Str. 22, München, 81675, Germany

      Günter Klöppel

    2. Inst. Pathologie, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Str. 1, Hannover, 30623, Germany

      Hans Kreipe

    3. Kliniken der Landeshauptstadt, Institut für Pathologie, Ludwig-Erhard-Straße 100, Wiesbaden, 65199, Germany

      Wolfgang Remmele

    4. Charite - Universitätsmedizin Berlin, Campus Charité Mitte, Institut für Pathologie, Charitéplatz 1, Berlin, 10117, Berlin, Germany

      Manfred Dietel

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2013 Springer-Verlag Berlin Heidelberg

    About this chapter

    Cite this chapter

    Dietel, M., Denkert, C., Darb-Esfahani, S. (2013). Ovar. In: Klöppel, G., Kreipe, H., Remmele, W., Dietel, M. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04564-6_21

    Download citation

    • DOI: https://doi.org/10.1007/978-3-642-04564-6_21

    • Published:

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-642-04563-9

    • Online ISBN: 978-3-642-04564-6

    • eBook Packages: Medicine (German Language)

    Publish with us

    Policies and ethics

    Search

    Navigation